Optiver Holding’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Buy
264,300
+83,400
+46% +$3.89M ﹤0.01% 331
2025
Q4
$8.77M Sell
180,900
-85,900
-32% -$4.26M ﹤0.01% 344
2025
Q3
$12.6M Buy
266,800
+103,400
+63% +$4.99M 0.01% 266
2025
Q2
$7.89M Buy
163,400
+15,400
+10% +$787K ﹤0.01% 190
2025
Q1
$8.21M Buy
148,000
+125,900
+570% +$6.81M ﹤0.01% 184
2024
Q4
$1.07M Buy
+22,100
New +$1.12M ﹤0.01% 381

Other funds holding SNY

Optiver Holding's SNY Position: Q1 2026 in Review

Optiver Holding increased its Sanofi (SNY) stake by 44% in Q1 2026, buying an estimated $7.03M and bringing the position to 493,829 shares worth $23.8M. The position accounts for 0.01% of the portfolio, ranked #258.

Optiver Holding first reported a position in SNY in Q4 2021 and has held it in 14 quarters since. The position peaked at $38.6M in Q2 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Optiver Holding held 493,829 shares of Sanofi worth $23.8M as of Q1 2026.
  • Optiver Holding bought 150,879 Sanofi shares in Q1 2026, an estimated $7.03M.
  • Sanofi made up 0.01% of Optiver Holding's portfolio in Q1 2026, its #258 holding.
  • Optiver Holding first reported a position in Sanofi in Q4 2021 and has held it in 14 quarters since.
  • Optiver Holding's Sanofi position peaked at $38.6M in Q2 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.